The Molecular Profiling Core (Core C) integrates with and enhances the capabilities of our existing Biotechnology Support Facility, Microarray Facility and new Genome Sequencing Facility, the first two with histories of success in augmenting and extending the research programs of investigators at KUMC. This core will assist COBRE investigators by providing cost-effective services for the synthesis of oligonucleotides, DNA sequence analysis, microarray chip processing and genome sequencing technologies. Eighty-three percent of our Center Members/Mentors (24/29) and 4 of the 5 previous cycle COBRE Beginning Investigators utilized these facilities during the last funding period. During the next funding period, there will be 5 Beginning Investigators and 29 Center Members/Mentors. The expectation is that usage will increase during the upcoming grant cycle. Historically, usage by this group of researchers accounts for 22% of all KUMC oligonucleotide synthesis, 97% of DNA sequencing and 33% of microarray chip analysis on an annual basis. A significant portion of this same faculty anticipates utilizing recently acquired NexGen sequencing capabilities. This facility will provide all COBRE scientists with services to synthesize oligonucleotides, obtain DNA sequence determination and analysis, supply microan-ay chips and chip processing technologies, and offer the latest genomic deep sequencing methodologies to center investigators. The COBRE funds will subsidize activities for the junior investigators and for members of the Center who use the core, and the institution will continue to provide significant state support for this facility. The Biotechnology Support Facility is staffed by a lab manager and three personnel. One of these personnel also serves as the project manager of the Microarray Facility and Project Supervisor of the Genome Sequencing Facility. All are experts with the methods required and will interface with the COBRE Molecular Profiling Core Director. The addition of services offered by the newly-established Genome Sequencing Facility's lllumina HiSeq 2000 Sequencing System will accelerate COBRE investigator research by performing large-scale sequencing studies on complex genomes, transcriptomes and epigenomes.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kansas
Kansas City
United States
Zip Code
Wang, Huizhen; Luo, Jinping; Carlton, Carol et al. (2017) Sperm-oocyte contact induces outside-in signaling via PYK2 activation. Dev Biol 428:52-62
Padró, Mercè; Louie, Raymond J; Lananna, Brian V et al. (2017) Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells. BMC Cancer 17:203
New, Jacob; Arnold, Levi; Ananth, Megha et al. (2017) Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target. Cancer Res 77:6679-6691
Rogers, Robert S; Tungtur, Sudheer; Tanaka, Tomohiro et al. (2017) Impaired Mitophagy Plays a Role in Denervation of Neuromuscular Junctions in ALS Mice. Front Neurosci 11:473
Lui, Asona J; Geanes, Eric S; Ogony, Joshua et al. (2017) IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett 399:29-43
Tan, Ee Phie; Duncan, Francesca E; Slawson, Chad (2017) The sweet side of the cell cycle. Biochem Soc Trans 45:313-322
Wilson, C; Qiu, L; Hong, Y et al. (2017) The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer. Oncogene 36:2565-2576
Chen, Lei; Zhao, Lin; Samanta, Anweshan et al. (2017) STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPK?/mTOR axis. PLoS One 12:e0179835
Jasti, Susmita; Farahbakhsh, Mina; Nguyen, Sean et al. (2017) Immune response to a model shared placenta/tumor-associated antigen reduces cancer risk in parous mice. Biol Reprod 96:134-144
Samanta, Saheli; Rajasingh, Sheeja; Cao, Thuy et al. (2017) Epigenetic dysfunctional diseases and therapy for infection and inflammation. Biochim Biophys Acta 1863:518-528

Showing the most recent 10 out of 58 publications